Clinical Trials Logo

Filter by:
NCT ID: NCT06175026 Completed - Food Selection Clinical Trials

Encouraging Healthy and Sustainable Dietary Substitutions

Start date: January 22, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to examine emerging adults' responses to dietary substitution messages about health, the environment, or both health and the environment.

NCT ID: NCT06175000 Recruiting - Clinical trials for Primary Central Nervous System Lymphoma

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

Start date: March 13, 2024
Phase: Phase 2
Study type: Interventional

This randomized phase II trial studies how well obinutuzumab works as maintenance treatment in patients with central nervous system lymphoma who have achieved the disappearance of all signs of cancer in response to treatment (complete response) or a decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment (partial response). Immunotherapy with obinutuzumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread.

NCT ID: NCT06174987 Recruiting - Metastatic Cancer Clinical Trials

A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

Start date: January 5, 2024
Phase: Phase 3
Study type: Interventional

This open-label, multicenter, rollover study will provide continued treatment for participants deriving benefit from different therapies received in studies sponsored by Daiichi Sankyo, Inc. (DS) or DS/Astra Zeneca (AZ)-sponsored study (eg. DS8201-A-J101, DS8201-A-U201, DS8201-A-U204, DS8201-A-U207, DS8201-A-U303).

NCT ID: NCT06174935 Not yet recruiting - Vitreous Floaters Clinical Trials

Low Dose Atropine for Symptomatic Vitreous Floaters

Start date: January 1, 2024
Phase: Phase 2
Study type: Interventional

The objective of this study is to identify a potential pharmacologic option by assessing whether 0.01% atropine may be effective for treating bothersome floaters as measured by scores on a modified NEI VFQ-25.

NCT ID: NCT06174883 Completed - Spina Bifida Clinical Trials

Salt-FA to Increase Folate Levels

Start date: June 1, 2022
Phase:
Study type: Observational

Question: How effective is folic acid-fortified iodized salt in increasing serum folate concentrations among non-pregnant and non-lactating women of reproductive age? Hypothesis: Folic acid-fortified iodized salt can increase serum folate levels and serve as a policy consideration in salt fortification with both iodine and folic acid to reduce serious and fatal birth defects.

NCT ID: NCT06174805 Not yet recruiting - Clinical trials for Gastric Outlet Obstruction

AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

To investigate the safety and technical success of EUS-guided gastroenterostomy (EUS-GE) using the AXIOSTM lumen-apposing Metal Stent for the management of symptoms associated with gastric outlet obstruction from malignant unresectable neoplasm.

NCT ID: NCT06174727 Recruiting - Clinical trials for Intracranial Aneurysm

International Registry of Flow Diverter Stents

IRF
Start date: October 1, 2023
Phase:
Study type: Observational

This multi-center retrospective cohort study aims to investigate the technical and clinical outcomes of intracranial aneurysms treated with Flow diverter stents.

NCT ID: NCT06174701 Not yet recruiting - Surgery Clinical Trials

PST in Surgery: Feasibility and Acceptability Pilot

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test problem solving therapy (PST) in older adults who are undergoing major surgery. The main question it aims to answer is: • What is the feasibility and acceptability of delivering PST to older surgical patients with depressive symptoms or report lacking social support in the pre-operative and post-operative setting?

NCT ID: NCT06174558 Not yet recruiting - Clinical trials for Obstructive Sleep Apnea

Is My Sleep Tracker Tracking my Sleep?

Start date: February 1, 2024
Phase:
Study type: Observational

The purpose of this research study is to collect health and physiological data using commercially available wristband fitness tracker devices (FitBit and Garmin devices) to help determine their accuracy and reliability at measuring percent of night spent in REM sleep, oxygen desaturation, and apnea hypopnea index compared with currently available methods of in-laboratory polysomnogram and home sleep testing.

NCT ID: NCT06174493 Not yet recruiting - Atopic Dermatitis Clinical Trials

Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials

Start date: January 2025
Phase:
Study type: Observational

Clinical trials, specifically focused on atopic dermatitis, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation. The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.